ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
Product List
Home / ARPOD-CV DRY SYP
ARPOD-CV DRY SYP

RHINOVENT-P

Product Packing: 10 ML

Product Composition: Xylometazolineá 0.05% + Benzalkonium chloride 0.02%

Product Price: MRP : 48

RHINOVENT-P

Xylometazoline 0.05% + Benzalkonium Chloride 0.02% | DROP 10 ML

RHINOVENT-P is a drop formulation containing Xylometazoline 0.05% and Benzalkonium Chloride 0.02%. Xylometazoline is a topical alpha-adrenergic decongestant commonly used in nasal preparations for short-term relief of nasal congestion. Benzalkonium Chloride may function as a preservative or formulation component depending on the approved product. The exact route and product specifications must be verified from the current approved label.

Xylometazoline constricts blood vessels in the nasal mucosa, reducing swelling and congestion. Because prolonged or excessive topical decongestant use can cause rebound congestion, treatment should be limited to the approved duration. Exact formulation role and labeling of Benzalkonium Chloride must follow the approved product specifications.

Composition

Each approved measured quantity contains:

·         Xylometazoline - 0.05%

·         Benzalkonium Chloride - 0.02%

·         Drop vehicle / excipients - q.s. Exact Xylometazoline salt equivalence, role of Benzalkonium Chloride, route, preservative system and complete excipient details must be verified from the current approved product label.

Dosage form: Drop

Pack size: 10 ml

Uses of RHINOVENT-P

Where approved as a nasal formulation, RHINOVENT-P may be used for short-term symptomatic relief of nasal congestion associated with appropriate conditions.

·         Helps reduce swelling of congested nasal mucosa

·         May provide temporary relief of a blocked or stuffy nose

·         Topical action can improve nasal airflow in appropriately selected patients

·         Use should be short term and consistent with the approved age range and dosing instructions

Persistent congestion, high fever, severe facial pain, recurrent nosebleeds, breathing difficulty or symptoms that worsen or do not improve require professional assessment.

How RHINOVENT-P Works

RHINOVENT-P contains Xylometazoline with Benzalkonium Chloride as specified in the supplied product brief:

Xylometazoline: A topical sympathomimetic/alpha-adrenergic decongestant that constricts blood vessels in the nasal mucosa and reduces swelling.

This vasoconstrictor effect can temporarily improve nasal airflow and relieve congestion.

Benzalkonium Chloride: Commonly used as an antimicrobial preservative in some topical formulations; its exact function in RHINOVENT-P must follow the approved formulation and label.

Clinical response and safety depend on the approved route, dose, frequency, treatment duration, age and individual cardiovascular or nasal conditions.

Excessive or prolonged topical decongestant use can lead to rebound congestion (rhinitis medicamentosa), so approved duration limits are important.

 

Dosage and Direction for Use

Use RHINOVENT-P strictly according to the current approved product label or healthcare professional's advice. Dose, frequency, age eligibility and treatment duration must not be inferred from the concentration alone.

If the approved route is nasal, clear the nose gently before administration and avoid touching the dropper tip to the nose, fingers or other surfaces.

Do not share the drop container with another person. Follow the approved administration technique and cleaning instructions.

Do not use more frequently or for longer than the approved duration because rebound congestion and systemic sympathomimetic effects may occur.

Possible Side Effects

Possible adverse effects may include:

·         Temporary nasal burning, stinging, dryness, irritation or sneezing when used nasally

·         Headache, nausea or local discomfort may occur in some users

·         Palpitations, increased blood pressure, nervousness, tremor or sleep disturbance may occur, particularly with excessive exposure or susceptible patients

·         Prolonged or excessive use may cause rebound congestion and worsening nasal obstruction

·         Benzalkonium Chloride-containing nasal formulations may cause local irritation in some patients, particularly with prolonged exposure.

·         Stop use and seek medical advice for severe headache, chest pain, marked palpitations, significant blood-pressure symptoms, severe allergy or other serious reactions.

Precautions and Contraindications

 

Avoid use in patients with known hypersensitivity to Xylometazoline, Benzalkonium Chloride or any formulation excipient.

·         Use caution in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, glaucoma or other conditions affected by sympathomimetic medicines.

·         Do not exceed the approved duration because prolonged topical decongestant use can cause rhinitis medicamentosa and persistent rebound congestion.

·         Concurrent or recent monoamine oxidase inhibitor (MAOI) therapy and certain antidepressants may increase cardiovascular effects; follow the approved contraindications and interaction guidance.

·         Pediatric use is age- and concentration-specific. Xylometazoline 0.05% is used in some pediatric nasal products, but the exact approved age range, dose and duration for RHINOVENT-P must be verified from the current label.

·         Pregnancy and breastfeeding require professional assessment before use.

·         Check the exact route, Xylometazoline salt equivalence, role of Benzalkonium Chloride, excipients, storage conditions and discard-after-opening instructions on the approved label.

·         Keep out of reach of children. Accidental ingestion or excessive administration can be dangerous, particularly in young children.

·         Drug Interaction Considerations

·         MAOIs, tricyclic antidepressants and other sympathomimetic medicines may increase blood-pressure or cardiovascular effects of Xylometazoline. Patients using antihypertensive or cardiovascular medicines should seek professional advice where relevant.

·         Tell the healthcare professional about prescription medicines, OTC cold/decongestant products and other nasal preparations being used before treatment.

Business Growth Opportunity with RHINOVENT-P

RHINOVENT-P offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add a Xylometazoline 0.05% + Benzalkonium Chloride 0.02% 10 ml drop formulation to an appropriately licensed ENT portfolio.

Promotion must remain strictly consistent with the approved route, age range, indications, duration, warnings, ingredient functions, permitted claims and applicable regulations.

 

Key Business Advantages

·         Xylometazoline 0.05% + Benzalkonium Chloride 0.02% formulation

·         Topical decongestant product concept subject to approved nasal route

·         Convenient drop dosage form

·         10 ml pack

·         Suitable addition to an appropriately licensed ENT portfolio subject to approved route and indications

·         Opportunity for ethical promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for RHINOVENT-P

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for RHINOVENT-P in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids consistent with approved claims

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for RHINOVENT-P and other quality-focused healthcare products.

Third-Party Manufacturing Support for Xylometazoline Drops

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to RHINOVENT-P under their own brand, subject to applicable drug licensing, regulatory and route-specific manufacturing requirements.

Our third-party manufacturing support may include:

·         Approved formulation and 10 ml pack configuration support, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies seeking to expand an appropriately licensed ENT product portfolio.

Frequently Asked Questions About RHINOVENT-P

1. What is RHINOVENT-P?

RHINOVENT-P is a 10 ml drop formulation containing Xylometazoline 0.05% and Benzalkonium Chloride 0.02% according to the supplied product brief.

2. What does Xylometazoline do?

Xylometazoline is a topical alpha-adrenergic decongestant that constricts blood vessels in the nasal mucosa and can temporarily reduce nasal congestion when used by an approved nasal route.

3. What is the role of Benzalkonium Chloride?

Benzalkonium Chloride is commonly used as an antimicrobial preservative in topical formulations, but its exact function in this product must be verified from the approved label.

4. Can RHINOVENT-P be used continuously for a long time?

No. Topical Xylometazoline should be used only for the approved short duration because prolonged or excessive use can cause rebound congestion.

5. Is Xylometazoline 0.05% suitable for children?

Pediatric suitability is age- and concentration-specific. Use in a child only when the approved label and a healthcare professional confirm the appropriate age, dose and duration.

6. How should RHINOVENT-P be used?

Use only by the route, dose, frequency and duration stated on the approved label or advised by a healthcare professional. Do not exceed the recommended duration.

7. Is a PCD Pharma Franchise available for RHINOVENT-P?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Xylometazoline + Benzalkonium Chloride drop may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing, manufacturing and regulatory requirements.

Disclaimer

RHINOVENT-P product information in this document is for general professional and business information. The supplied product brief states Xylometazoline 0.05% + Benzalkonium Chloride 0.02%, DROP 10 ML, but does not explicitly state the administration route. Xylometazoline is commonly used in nasal decongestant preparations, but the exact route has not been assumed as a confirmed product specification. Exact Xylometazoline salt equivalence, role of Benzalkonium Chloride, approved route, indications, dosage/frequency, age range, treatment duration, prescription/product classification, contraindications, warnings, interactions, excipient system, manufacturing specifications, storage and discard-after-opening instructions must be verified against the current approved product label before manufacture, promotion, recommending, dispensing or use. Prolonged topical decongestant use can cause rebound congestion. This document is not a substitute for professional medical advice.

Contact